−0.41USD
−1.35 MUSD
5.31 M
About XTL Biopharmaceuticals Ltd.
Sector
Industry
CEO
Shlomo Spokone Shalev
Website
Headquarters
Ramat Gan
Employees (FY)
8
Founded
1993
ISIN
US98386D3070
FIGI
BBG000F1JVP4
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
